ClinVar Miner

Submissions for variant NM_003060.4(SLC22A5):c.839C>T (p.Ser280Phe)

gnomAD frequency: 0.00001  dbSNP: rs386134208
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV002035333 SCV002232275 pathogenic Renal carnitine transport defect 2024-02-01 criteria provided, single submitter clinical testing This sequence change replaces serine, which is neutral and polar, with phenylalanine, which is neutral and non-polar, at codon 280 of the SLC22A5 protein (p.Ser280Phe). This variant is present in population databases (rs386134208, gnomAD 0.006%). This missense change has been observed in individual(s) with primary carnitine deficiency (PMID: 28841266, 29132460). ClinVar contains an entry for this variant (Variation ID: 1451545). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SLC22A5 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects SLC22A5 function (PMID: 28841266). This variant disrupts the p.Ser280 amino acid residue in SLC22A5. Other variant(s) that disrupt this residue have been determined to be pathogenic (Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.
Baylor Genetics RCV002035333 SCV004201256 likely pathogenic Renal carnitine transport defect 2024-03-19 criteria provided, single submitter clinical testing
Fulgent Genetics, Fulgent Genetics RCV002035333 SCV005669217 pathogenic Renal carnitine transport defect 2024-05-10 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.